Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus

Clinical Infectious Diseases

Volumn 34, Issue 1, 2002, Pages 7-14

  Ascioglu, S ^a   Rex, J H ^b   De Pauw, B ^a   Bennett, J E ^b   Bille, J ^a   Crokaert, F ^a   Denning, D W ^a   Donnelly, J P ^a   Edwards, J E ^b   Erjavec, Z ^a   Fiere, D ^a   Lortholary, O ^a   Maertens, J ^a   Meis, J F ^a   Patterson, T F ^b   Ritter, J ^a   Selleslag, D ^a   Shah, P M ^a   Stevens, D A ^b   Walsh, T J ^b  

^a EORTC DATA CENTER   (Belgium)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASPERGILLOSIS; CANCER; CANDIDIASIS; CLINICAL FEATURE; CLINICAL PRACTICE; EUROPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; MYCOSIS; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL;

ASPERGILLOSIS; CANDIDIASIS; DECISION MAKING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; NEOPLASMS; OPPORTUNISTIC INFECTIONS;

EID: 0036133373     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/323335     Document Type: Article

References (35)

1. Probabilistic reasoning in clinical medicine: Problems and opportunities
2. Does inappropriate use explains geographic variations in the use of health care services? A study of three procedures
3. Evidence based medicine: What it is and what it isn't
4. Potential benefits, limitations, and harms of clinical guidelines
5. Developing case definitions for symptom-based conditions: The problem of specificity
6. Evaluation of diagnostic ('classification') criteria in Behçet's disease - Towards internationally agreed criteria
7. The American College of Rheumatology 1990 criteria for the classification of vasculitis
8. Evaluation of new clinical criteria for the diagnosis of infective endocarditis
9. Prospective cohort studies: Planning and execution
10. Reliability of clinical research on invasive fungal infections: A systematic review of the literature
11. Measuring the vague meanings of probability terms
12. The effect of misclassification of disease status in follow-up studies: Implications for selecting disease classification criteria
13. The use and misuse of classification and diagnostic criteria for complex diseases
14. Expressions of probability: Words and numbers [letter]
15. Our stubborn quest for diagnostic certainty
16. Dealing with uncertainty, risks, and tradeoffs in clinical decisions: A cognitive science approach
17. Comparison of radioimmunoassay and enzyme-linked immunoassay methods for detection of Histoplasma capsulatum var. capsulatum antigen
18. Diagnosis of invasive fungal infections: Advances in nonculture systems
19. Infections due to Trichosporon species: New concepts in mycology, pathogenesis, diagnosis, and treatment
20. Cross-reactivity between Stomatococcus mucilaginosus and latex agglutination for cryptococcal antigen
21. Effect of potential interference factors on performance of enzyme immunoassay and latex agglutination assay for cryptococcal antigen
22. Diagnostic value of cryptococcal antigen in the cerebrospinal fluid of patients with malignant disease
23. Statistical approaches to classification
24. Hospital epidemiologic surveillance for invasive aspergillosis: Patient demographics and the utility of antigen detection
25. Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: The potential role of bronchoalveolar lavage D-mannitol and galactomannan as markers of infection
26. Current trends in the detection of antigenaemia, metabolites, and cell wall markers for the diagnosis and therapeutic monitoring of fungal infections
27. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis
28. Detection and identification of fungal pathogens in blood by using molecular probes
29. Candidemia in a tertiary care hospital: Epidemiology, risk factors, and predictors of mortality
30. Predictors of adverse outcome in cancer patients with candidemia
31. Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis: Disseminated versus single organ infection
32. Vascular catheter-associated fungemia in patients with cancer: Analysis of 155 episodes
33. Editorial response: Should all patients with candidemia he treated with antifungal agents?
34. Evolving risk factors for invasive fungal infections: All neutropenic patients are not the same
35. Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis: Results of a three-year prospective study